Development of Angiogenic Effects on Tumor Micrometastasis_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

LUO Chengyu ¹ , ZHU Xueguang ²

Department of General Surgery, Affiliated Beijing Fuxing Hospital, Capital University of Medicine and Science, Beijing 100038, China;

Corresponding author：

Keywords：

NeoplasmMetastasisAngiogenesis

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

ObjectiveTo discuss the angiogenic effects on tumor micrometastasis. MethodsLiteratures on the relation between tumor angiogenesis and micrometastasis were reviewed. ResultsTumor angiogenesis was a basis of the development of micrometastasis.Conclusion Micrometastic dependence on angiogenesis gestates a novel revolution of tumor treatment.

Citation： LUO Chengyu,ZHU Xueguang. Development of Angiogenic Effects on Tumor Micrometastasis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2003, 10(5): 516-518. doi: Copy

1.	骆成玉. 大肠癌患者外周血中癌细胞检测的临床意义 [J].中华实验外科杂志， 1999; 16（3）∶199.
2.	骆成玉，赵丹宁，曾胜. 大肠癌淋巴结微转移的预后意义 [J].中华普通外科杂志， 2000; 15（3）∶133.
3.	骆成玉. 大肠癌患者门静脉血癌细胞的检测及临床意义 [J].中华外科杂志， 1999; 37（4）∶214.
4.	骆成玉，苑树俊. 手术前后大肠癌骨髓微转移的研究 [J].中华实验外科杂志， 2000; 17（3）∶275.
5.	骆成玉，赵丹宁. 大肠癌淋巴结微转移的研究 [J].中华外科杂志，2000; 38（2）∶142.
6.	Faviana P, Boldrini L, Spisni R, et al.Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression [J]. Oncol Rep, 2002; 9(3)∶617.
7.	骆成玉，赵丹宁，李世拥. 大肠癌术后血路播散的动态追踪监测 [J]. 中华普通外科杂志, 2001; 16（2）∶118.
8.	骆成玉，赵丹宁，刘元林. 内皮抑素对结肠癌肝转移的干预作用 [J]. 中华外科杂志, 2001; 39（3）∶198.
9.	骆成玉，赵丹宁. 腺病毒介导的内皮抑素基因转移预防大肠癌术后肝转移 [J]. 中华外科杂志, 2002; 40（5）∶375.
10.	骆成玉,赵丹宁,曾胜,等. 大肠癌患者腹腔微量游离癌细胞的研究 [J]. 中华外科杂志, 2001; 39（6）∶433.
11.	骆成玉，赵丹宁. 术后复发转移的大肠癌血路播散分析 [J].中华普通外科杂志， 2001; 16（5）∶291.
12.	Folkman J.Tumour angiogenesis and tissue factor [J]. Nat Med,1996; 2(2)∶167.
13.	Ingber DE.Extracellular matrix and cell shape:potential control points for inhibition of angiogenesis [J]. J Cell Biochem, 1991； 47(3)∶236.
14.	Lawler J. Thrombospondin1 as an endogenous inhibitor of angiogenesis and tumor growth [J]. J Cell Mol Med, 2002； 6(1)∶1.
15.	Brivio F, Lissoni P, Rovelli F,et al. Effects of IL2 preoperative immunotherapy on surgeryinduced changes in angiogenic regulation and its prevention of VEGF increase and IL12 decline [J].Hepatogastroenterology, 2002； 49(44)∶385.
16.	Svendsen MN, Werther K, Nielsen HJ, et al.EGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion [J]. Scand J Gastroenterol, 2002; 37(4)∶373.
17.	Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix [J]. Mol Biotechnol, 2002; 21(1)∶85.
18.	Yokoyama M, Ochi K, Ichimura M, et al. Matrix metalloproteinase2 in pancreatic juice for diagnosis of pancreatic cancer [J]. Pancreas, 2002; 24(4)∶344.
19.	McNamara DA, Harmey JH, Walsh TN, et al. Significance of angiogenesis in cancer therapy [J]. Br J Surg, 1998; 85(8)∶1044.
20.	骆成玉，曾胜，赵丹宁，等. 肌肉注射内皮抑素基因抑制人大肠癌生长的研究 [J].中华实验外科杂志， 2001; 18(5)∶443.
21.	O’Reilly MS, Boehm T, Shing Y, et al.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997; 88(2)∶277.
22.	Teicher BA, Emi Y, Kakeji Y, et al.TNP470/Minocycline/cytotoxic therapy: a systems approach to cancer therapy [J]. Eur J Cancer, 1996; 32A(14)∶2461.
23.	Kakeji Y, Maehara Y, Sumiyoshi Y, et al. Angiogenesis as a target for gastric cancer [J]. Surgery, 2002; 131(1 Suppl)∶S48.
24.	Papetti M, Herman IM. Mechanisms of normal and tumorderived angiogenesis [J]. Am J Physiol Cell Physiol， 2002; 282(5)∶C947.
25.	Mohr L, Shankara S, Yoon SK, et al.Gene therapy of hepatocellar carcinoma in vitro and in vovo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene [J]. Hepatology, 2000; 31(3)∶606.
26.	Skobe M, Rockwell P, Goldstein N, et al.Halting angiogenesis supresses carcinoma cell invasion [J].Nat Med, 1997; 3(11)∶1222.

1. 骆成玉. 大肠癌患者外周血中癌细胞检测的临床意义 [J].中华实验外科杂志， 1999; 16（3）∶199.
2. 骆成玉，赵丹宁，曾胜. 大肠癌淋巴结微转移的预后意义 [J].中华普通外科杂志， 2000; 15（3）∶133.
3. 骆成玉. 大肠癌患者门静脉血癌细胞的检测及临床意义 [J].中华外科杂志， 1999; 37（4）∶214.
4. 骆成玉，苑树俊. 手术前后大肠癌骨髓微转移的研究 [J].中华实验外科杂志， 2000; 17（3）∶275.
5. 骆成玉，赵丹宁. 大肠癌淋巴结微转移的研究 [J].中华外科杂志，2000; 38（2）∶142.
6. Faviana P, Boldrini L, Spisni R, et al.Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression [J]. Oncol Rep, 2002; 9(3)∶617.
7. 骆成玉，赵丹宁，李世拥. 大肠癌术后血路播散的动态追踪监测 [J]. 中华普通外科杂志, 2001; 16（2）∶118.
8. 骆成玉，赵丹宁，刘元林. 内皮抑素对结肠癌肝转移的干预作用 [J]. 中华外科杂志, 2001; 39（3）∶198.
9. 骆成玉，赵丹宁. 腺病毒介导的内皮抑素基因转移预防大肠癌术后肝转移 [J]. 中华外科杂志, 2002; 40（5）∶375.
10. 骆成玉,赵丹宁,曾胜,等. 大肠癌患者腹腔微量游离癌细胞的研究 [J]. 中华外科杂志, 2001; 39（6）∶433.
11. 骆成玉，赵丹宁. 术后复发转移的大肠癌血路播散分析 [J].中华普通外科杂志， 2001; 16（5）∶291.
12. Folkman J.Tumour angiogenesis and tissue factor [J]. Nat Med,1996; 2(2)∶167.
13. Ingber DE.Extracellular matrix and cell shape:potential control points for inhibition of angiogenesis [J]. J Cell Biochem, 1991； 47(3)∶236.
14. Lawler J. Thrombospondin1 as an endogenous inhibitor of angiogenesis and tumor growth [J]. J Cell Mol Med, 2002； 6(1)∶1.
15. Brivio F, Lissoni P, Rovelli F,et al. Effects of IL2 preoperative immunotherapy on surgeryinduced changes in angiogenic regulation and its prevention of VEGF increase and IL12 decline [J].Hepatogastroenterology, 2002； 49(44)∶385.
16. Svendsen MN, Werther K, Nielsen HJ, et al.EGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion [J]. Scand J Gastroenterol, 2002; 37(4)∶373.
17. Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix [J]. Mol Biotechnol, 2002; 21(1)∶85.
18. Yokoyama M, Ochi K, Ichimura M, et al. Matrix metalloproteinase2 in pancreatic juice for diagnosis of pancreatic cancer [J]. Pancreas, 2002; 24(4)∶344.
19. McNamara DA, Harmey JH, Walsh TN, et al. Significance of angiogenesis in cancer therapy [J]. Br J Surg, 1998; 85(8)∶1044.
20. 骆成玉，曾胜，赵丹宁，等. 肌肉注射内皮抑素基因抑制人大肠癌生长的研究 [J].中华实验外科杂志， 2001; 18(5)∶443.
21. O’Reilly MS, Boehm T, Shing Y, et al.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997; 88(2)∶277.
22. Teicher BA, Emi Y, Kakeji Y, et al.TNP470/Minocycline/cytotoxic therapy: a systems approach to cancer therapy [J]. Eur J Cancer, 1996; 32A(14)∶2461.
23. Kakeji Y, Maehara Y, Sumiyoshi Y, et al. Angiogenesis as a target for gastric cancer [J]. Surgery, 2002; 131(1 Suppl)∶S48.
24. Papetti M, Herman IM. Mechanisms of normal and tumorderived angiogenesis [J]. Am J Physiol Cell Physiol， 2002; 282(5)∶C947.
25. Mohr L, Shankara S, Yoon SK, et al.Gene therapy of hepatocellar carcinoma in vitro and in vovo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene [J]. Hepatology, 2000; 31(3)∶606.
26. Skobe M, Rockwell P, Goldstein N, et al.Halting angiogenesis supresses carcinoma cell invasion [J].Nat Med, 1997; 3(11)∶1222.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Development of Angiogenic Effects on Tumor Micrometastasis

Abstract Full text Figures/Tables Video References Cited by

Format

Content